Tatva Chintan Pharma Chem Ltd Schedules Analyst Meeting with Motilal Oswal AMC

Tatva Chintan Pharma Chem Ltd Schedules Analyst Meeting with Motilal Oswal AMC

Tatva Chintan Pharma Chem Ltd Schedules Analyst Meeting with Motilal Oswal AMC​

Tatva Chintan Pharma Chem Limited has set a schedule for an analyst meeting, in which the company will participate with industry professionals. The interaction is focused on presenting information to financial institutions regarding the company's status.

The scheduled engagement is set to take place with Motilal Oswal AMC. The details of this One to One Meeting are as follows:

DateAnalyst/Financial InstitutionTypeMode
31 July 2026Motilal Oswal AMCOne to One MeetingVirtual Meeting

The company has stated that for the discussions held during this interaction, Tatva Chintan Pharma Chem Limited will be referencing publicly available information. The company confirmed that no confidential or unpublished price sensitive information will be shared during the meeting.

TATVA Stock Price Movement​

Shares of Tatva Chintan Pharma Chem Limited are edging higher to ₹1701 as of 1:17 PM, gaining slightly by 0.01% in live trading. The stock sees a moderate traded volume of 100,755 shares, as the company trades within a daily range defined by highs near ₹1720.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Editorial Note

This news article was written and created by Deepali, and published on IST.
Back
Top